These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8169033)

  • 21. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.
    Ueno T; Inuzuka S; Sata M; Koh H; Tamaki S; Kin M; Sugawara H; Sakata R; Torimura T; Tanikawa K
    Hepatogastroenterology; 1995; 42(5):522-7. PubMed ID: 8751209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Number V Oral lichen planus: clinical features and management.
    Eisen D; Carrozzo M; Bagan Sebastian JV; Thongprasom K
    Oral Dis; 2005 Nov; 11(6):338-49. PubMed ID: 16269024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Alpha-interferon in the treatment of chronic hepatitis C in children].
    Cinquetti M; Marchi D
    Pediatr Med Chir; 1995; 17(6):501-7. PubMed ID: 8668583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of chronic viral hepatitis].
    Marcellin P; Metreau JM; Pol S; Zoulim F
    Ann Gastroenterol Hepatol (Paris); 1996; 32(2):85-7. PubMed ID: 8737503
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cost-effectiveness analysis of the treatment of chronic hepatitis C].
    Joliot E; Vanlemmens C; Kerleau M; Le Gales C; Woronoff-Lemsi MC; Flori YA; Seror V; Hrusovsky S; Monnet E; Bresson-Hadni S; Miguet JP
    Gastroenterol Clin Biol; 1996; 20(11):958-67. PubMed ID: 9119185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral lichen planus: a review.
    Mollaoglu N
    Br J Oral Maxillofac Surg; 2000 Aug; 38(4):370-7. PubMed ID: 10922170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Association of chronic hepatitis C and lichen planus--in two patients].
    Podányi B; Lengyel G; Kiss A; Szakonyi J; Schaff Z; Fehér J
    Orv Hetil; 2006 Mar; 147(12):547-50. PubMed ID: 16696378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral lichenoid lesions in HIV-HCV-coinfected subjects during antiviral therapy: 2 cases and review of the literature.
    Giuliani M; Lajolo C; Sartorio A; Scivetti M; Capodiferro S; Tumbarello M
    Am J Dermatopathol; 2008 Oct; 30(5):466-71. PubMed ID: 18806491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lichen planus induced by interferon-alpha-2a therapy for chronic active hepatitis C.
    Barreca T; Corsini G; Franceschini R; Gambini C; Garibaldi A; Rolandi E
    Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):367-8. PubMed ID: 7600144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral lichen planus.
    Huber MA
    Quintessence Int; 2004 Oct; 35(9):731-52. PubMed ID: 15470998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [How should hepatitis C be monitored? Monitoring of treated hepatitis C].
    Larrey D
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S99-110. PubMed ID: 9161521
    [No Abstract]   [Full Text] [Related]  

  • 32. Oral lichen planus, hepatitis C virus, and HIV: no association in a cohort study from an area of high hepatitis C virus endemicity.
    Campisi G; Di Fede O; Craxi A; Di Stefano R; Margiotta V
    J Am Acad Dermatol; 2004 Sep; 51(3):364-70. PubMed ID: 15337978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Thyroid dysfunction in patients with chronic hepatitis C pre and post treatment with interferon].
    Martín-Vivaldi R; Nogueras F; Quintero D; Espinosa MD; López de Hierro M; Suárez JF; González A
    Rev Esp Enferm Dig; 1996 Jul; 88(7):480-4. PubMed ID: 8924326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Appearance of oral erosive lichen planus during interferon alfa-2a therapy for chronic active hepatitis C.
    Núñez M; Miralles ES; de las Heras ME; Ledo A
    J Dermatol; 1995 Jun; 22(6):461-2. PubMed ID: 7650248
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of chronic hepatitis C with interferon alfa-n3: a multicenter, randomized, open-label trial.
    Simon DM; Gordon SC; Kaplan MM; Koff RS; Regenstein F; Everson G; Lee YM; Weiner F; Silverman A; Plasse T; Fedorczyk D; Liao MJ
    Hepatology; 1997 Feb; 25(2):445-8. PubMed ID: 9021962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Compared efficiency of three strategies of management of chronic hepatitis C. Effect on the risk of cirrhosis 8 years after diagnosis].
    Michel P; Merle V; Gourier C; Hochain P; Colin R; Czernichow P
    Gastroenterol Clin Biol; 1996 Feb; 20(1):47-54. PubMed ID: 8734312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Five cases of drug-induced pneumonitis due to Sho-saiko-to or interferon-alpha or both].
    Nakagawa A; Yamaguchi T; Takao T; Amano H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec; 33(12):1361-1366. PubMed ID: 8821988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C.
    Glück T; Seelig R; Dette S; Bühring HJ; Renz M; Kwon S; Wiedmann KH; Weber P
    Hepatogastroenterology; 1997; 44(14):484-91. PubMed ID: 9164523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linear lichen planus and hepatitis C.
    Domínguez MV; Mateu AV; Vieira R; Solano JL; Sintes RN; Salmerón MT
    Dermatol Online J; 2006 Feb; 12(2):17. PubMed ID: 16638410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Interferon alpha and chronic viral hepatitis].
    Ouzan D
    Rev Prat; 1994 Sep; 44(13):1714-8. PubMed ID: 7939251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.